NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

If there is an accelerated pathway for Direct in India that would be a huge threat to all big pharmas including Merck. Closed system process is already available and product release standards may not be as strict in India as they are in the EU or UK even though these are the standards that NWBO and Advent have been living up to. Scale up there would be cost effective and rapid due to availability of qualified work force and motivation. The pressure on other regulators to move to tissue agnostic designation quickly would be potentially huge if India is already thinking along those lines with any accelerated pathway. Lots to think about and look in to. Best wishes.